CELATOR PHARMACEUTICALS INC's ticker is CPXX and the CUSIP is 15089R102. A total of 123 filers reported holding CELATOR PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.44 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $7,261,248,000 | – | 240,598 | – | 2.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,246,469 | $3,729,000 | 5.03% |
| TFS CAPITAL LLC | 22,443 | $37,000 | 0.00% |
| UBS Group AG | 500 | $1,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 67,015 | $111,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 25 | $0 | 0.00% |
| CITIGROUP INC | 135 | $0 | 0.00% |
| NORTHERN TRUST CORP | 20,724 | $35,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 34,795 | $58,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,200 | $4,000 | 0.00% |
| MORGAN STANLEY | 456 | $1,000 | 0.00% |